45 /100
MEDIUM RISK
Score updated Jul 14, 2026

PTIX — Protagenic Therapeutics, Inc. Dilution Risk Tracker

Track PTIX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PTIX — Get alerts when the score changes →

As of July 14, 2026, Protagenic Therapeutics, Inc. (PTIX) has a DilutionWatch DilutionScore of 45/100, rated MEDIUM dilution risk. Protagenic Therapeutics, Inc. has a market capitalization of $982.9K, 1.81M shares outstanding. Key dilution vectors include 81.6K outstanding warrants, approximately 6 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊 Float Risk
20
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
40%
🔄 Reverse Split 65%
• 50-day avg $0.65 below $1 exchange minimum
• 6 months cash with weak price
💰 Capital Raise 15%
• Under 12 months cash (6mo)
🔁 Convertible Conversion 15%
• Convertible debt present: 12.9% potential dilution
🔔 Track PTIX — Get forecast alerts →

💹 Market Data

Market Cap$982.9K
Shares Outstanding1.81M
FloatN/A
Cash$1.78M
Debt$4.00M
Short InterestN/A

🏛 Institutional Holdings

4.6% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track PTIX for full holder detail →

📉 Short Interest

Short Interest13.0K
Days to Cover1.6
% of FloatN/A
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2023
Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for PTIX Shareholders

Protagenic Therapeutics, Inc. (PTIX) has a DilutionScore of 45/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

Cash runway is a key watch item: PTIX has approximately 6 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for PTIX in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for PTIX alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track PTIX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PTIX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

AAT ACH AHRT ALOT AMPH

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for PTIX
📊 PTIX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PTIX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.